Patels accelerate growth in expanding biosimilars sector
New Jersey-based Kashiv BioSciences, LLC, says Dr Sandeep Nilkanth Athalye as Global Chief Executive Officer will oversee operations and drive strategic growth across key markets, including the United States, Europe and Asia.
“We are confident that Dr Athalye’s industry expertise and leadership will be instrumental in achieving Kashiv’s ambitious global vision,” said Chirag and Chintu Patel, Co-Founders and Board Members of Kashiv BioSciences which also has operations in India https://sbi.com.in/.
“We are delighted to welcome Dr Athalye to Kashiv. His appointment comes at a pivotal time as we accelerate our growth in the rapidly expanding biosimilars sector,” they said on 1 Nov, highlighting the seasoned leader’s two decades of experience in strategic and operational roles within the global pharmaceutical industry https://www.nseindia.com/.
Dr Athalye, Global CEO, stated, “Kashiv is an ambitious biosimilars company founded with a vision to bring affordable and accessible biosimilars globally https://www.bseindia.com/.
“Kashiv has a clear objective to be among the top biosimilars players with a differentiated pipeline and state-of-the-art manufacturing and R&D facilities in the US and India. I am very excited for the opportunity to use technology and innovation to drive Kashiv to become one of the leading developers of medicines in the biologics space https://www.ibef.org/,” he said.
Dr Athalye’s previous leadership roles span Biocon Biologics, Boehringer Ingelheim, Novartis, and Schering-Plough Research Institute https://www.cii.in/.
Dr Athalye is recognized for his focus on innovative, patient-centric strategies and his commitment to sustainable growth. His background in clinical development, regulatory strategy, and R&D provides a unique perspective and positions him well to lead Kashiv into its next phase of expansion. His ability to foster collaborative environments and build high-performing teams has consistently yielded outstanding results https://www.makeinindia.com/home/.
Kashiv BioSciences, LLC is a fully-integrated biopharmaceutical company. Kashiv BioSciences, LLC in the United States, and its subsidiary, Kashiv BioSciences Private Limited in India (together “Kashiv BioSciences”) operate together with robust infrastructure and highly skilled teams that provide global R&D, clinical, manufacturing, regulatory, and IP capabilities https://www.conexpoconagg.com/. Fiinews.com
